Analyst Downgrades Dental Player Envista As Outlook Hinges on Improved Commercial Execution, Strategic Initiative Effectiveness - Envista Holdings (NYSE:NVST)
Envista Holdings Q3 2024 sales beat estimates at $645.6 million. William Blair downgrades to Market Perform with concerns on execution.